IE33944L - Treatment of mastitis - Google Patents
Treatment of mastitisInfo
- Publication number
- IE33944L IE33944L IE700062A IE6270A IE33944L IE 33944 L IE33944 L IE 33944L IE 700062 A IE700062 A IE 700062A IE 6270 A IE6270 A IE 6270A IE 33944 L IE33944 L IE 33944L
- Authority
- IE
- Ireland
- Prior art keywords
- mastitis
- immuno
- globulin
- globulins
- cows
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
1297011 Mastitis immuno-globulins AGRICURA LABORATORIA Ltd 19 Jan 1970 [17 Jan 1969 13 March 1969] 2582/70 Heading A5B Mastitis immuno-globulin and polyvalent mastitis immunoglobulin are prepared by a process which comprises (a) mixing blood, which is obtained from one or more cows (where the word cows may include sheep ewes and she goats) which are suffering from chronic mastitis and/or are in a hyperimmune state with respect to mastitis, with an anticoagulant and an antihaemolytic; (b) removing the blood cells by centrifuging to form a plasma; (c) converting the plasma to a gel by adding calcium chloride solution; (d) straining the gel to produce a serum; (e) precipitating the mastitis immuno-globulin from the serum by adding ammonium sulphate solution; (f) filtering off the mastitis immuno-globulin and removing ammonium sulphate by dialysis; (g) removing large molecule protein impurities by centrifuging. The globulins may be used in the form of compositions containing a preservative such as phenol and/or one or more antibiotics selected from penicillin G. semisynthetic penicillions, streptomycin, dihydrostreptomycin or the sulphate thereof, F furazolidone, erythromycin, novobiocin, neomycin, bacitracin and chloramphenicol. The product may be freeze dried.
[GB1297011A]
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ZA69333 | 1969-01-17 | ||
ZA691780 | 1969-03-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
IE33944L true IE33944L (en) | 1970-07-17 |
IE33944B1 IE33944B1 (en) | 1974-12-11 |
Family
ID=27130988
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE62/70A IE33944B1 (en) | 1969-01-17 | 1970-01-16 | Improvements in or relating to the treatment of mastitis in cows,the product for this treatment and to the production of said product |
Country Status (16)
Country | Link |
---|---|
AT (1) | AT309134B (en) |
BE (1) | BE744515A (en) |
CA (1) | CA954045A (en) |
CH (1) | CH560543A5 (en) |
DE (1) | DE2001671C3 (en) |
DK (1) | DK128981B (en) |
ES (1) | ES375511A1 (en) |
FR (1) | FR2034472B1 (en) |
GB (1) | GB1297011A (en) |
IE (1) | IE33944B1 (en) |
IL (1) | IL33614A (en) |
IT (1) | IT1044200B (en) |
MT (1) | MTP639B (en) |
NL (1) | NL164746C (en) |
NO (1) | NO130179B (en) |
OA (1) | OA03892A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL1019143C2 (en) * | 2001-10-08 | 2003-04-09 | Nutricia Nv | Pharmaceutical product or dietary supplement and an intermediate product to be used. |
-
1969
- 1969-12-26 IL IL33614A patent/IL33614A/en unknown
-
1970
- 1970-01-09 AT AT514671A patent/AT309134B/en not_active IP Right Cessation
- 1970-01-14 CH CH47670A patent/CH560543A5/de not_active IP Right Cessation
- 1970-01-14 MT MT639A patent/MTP639B/en unknown
- 1970-01-15 NO NO70145A patent/NO130179B/no unknown
- 1970-01-15 DE DE2001671A patent/DE2001671C3/en not_active Expired
- 1970-01-16 CA CA072,282A patent/CA954045A/en not_active Expired
- 1970-01-16 BE BE744515D patent/BE744515A/en not_active IP Right Cessation
- 1970-01-16 FR FR7001552A patent/FR2034472B1/fr not_active Expired
- 1970-01-16 ES ES375511A patent/ES375511A1/en not_active Expired
- 1970-01-16 IE IE62/70A patent/IE33944B1/en unknown
- 1970-01-16 DK DK19270AA patent/DK128981B/en unknown
- 1970-01-16 NL NL7000637.A patent/NL164746C/en not_active IP Right Cessation
- 1970-01-17 OA OA53835A patent/OA03892A/en unknown
- 1970-01-17 IT IT47859/70A patent/IT1044200B/en active
- 1970-01-19 GB GB1297011D patent/GB1297011A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
BE744515A (en) | 1970-07-01 |
IL33614A (en) | 1973-08-29 |
FR2034472B1 (en) | 1974-03-22 |
IL33614A0 (en) | 1970-02-19 |
DK128981B (en) | 1974-08-05 |
IT1044200B (en) | 1980-03-20 |
DE2001671A1 (en) | 1970-07-30 |
MTP639B (en) | 1970-07-22 |
NL164746B (en) | 1980-09-15 |
CH560543A5 (en) | 1975-04-15 |
DE2001671C3 (en) | 1981-10-08 |
ES375511A1 (en) | 1973-04-16 |
GB1297011A (en) | 1972-11-22 |
FR2034472A1 (en) | 1970-12-11 |
CA954045A (en) | 1974-09-03 |
OA03892A (en) | 1975-08-14 |
NO130179B (en) | 1974-07-22 |
DK128981C (en) | 1975-01-20 |
NL164746C (en) | 1981-02-16 |
IE33944B1 (en) | 1974-12-11 |
NL7000637A (en) | 1970-07-21 |
DE2001671B2 (en) | 1980-09-25 |
AT309134B (en) | 1973-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3869436A (en) | Method for fractionating plasma proteins using peg and ion-exchangers | |
SU447876A1 (en) | Antitrombin isolation method | |
US4278594A (en) | Process for separation and isolation of AHF, von Willebrand's ristocetin cofactor (VWF:RCF) and fibronectin from blood plasma | |
US2390074A (en) | Protein product and process | |
US4210580A (en) | Process for separation and isolation of AHF and fibronectin from blood plasma | |
Goebel et al. | COLICINE K: II. The Preparation and Properties of a Substance Having Colicine K Activity | |
US2469193A (en) | Protein fractionation | |
Tishkoff et al. | Preparation of Highly Purified Prothrombin Complex: I. CRYSTALIZATION, BIOLOGICAL ACTIVITY, AND MOLECULAR PROPERTIES | |
US4089944A (en) | Rapidly solubilized AHF composition and process for preparing same | |
GB1487169A (en) | Production of egg white substitute from whey | |
Aoki et al. | Properties of bovine Ac-globulin concentrates and methods of preparation | |
US4312949A (en) | Method for the preparation of a gamma globulin solution suitable for intravenous use | |
Zittle et al. | Use of butanol in the purification of the alkaline phosphatase of bovine milk | |
IE33944L (en) | Treatment of mastitis | |
Hill | The preparation of K-casein | |
US2770616A (en) | Fractionation of proteinaceous materials in blood plasma and liver tissue | |
JPS6034916A (en) | High purity purification of ix factor and other vitamin k dependent proteins | |
US4027012A (en) | Process for the extraction of components having anticoagulant activity "in vivo" from snake venoms and products obtained | |
SU624562A3 (en) | Method of producing substance exhibiting hormonal action | |
IE36980B1 (en) | Isolation of orgotein | |
Van Creveld et al. | The separation of AHF from fibrinogen | |
US2974088A (en) | Method of preparing growth hormone | |
GB1293795A (en) | Improvements relating to anticoagulants | |
US2065196A (en) | Method for purification of antitoxins and the like | |
US4308204A (en) | Process for preparing the third component of the complement from human blood plasma |